OpportunityUniverse

Nature Awards - MDx Impact Grants 2026

助成金 一部支援 締め切り済み
今回の締め切りは終了しました。保存しておくと次回の募集開始時に通知が届きます。下の類似の機会もご覧ください。
Nature Awards 全世界 2026

情報

The MDx Impact Grants support projects that leverage PCR technology to improve diagnostics for Alzheimer’s Disease, aiming to develop tests that address unmet clinical needs and enhance patient outcomes. Researchers are invited to propose studies utilising Seegene’s high-multiplex PCR platform to detect and characterise molecular markers related to disease staging and progression. Grants offer financial support and access to diagnostic technology through collaboration with a diagnostics company. Awards of up to USD 600,000 are available per clinical study.

特典

Up to USD 600,000 in financial support per clinical study; access to Seegene’s syndromic PCR technology; collaboration/support from a leading diagnostic company.

応募資格

Research groups with experience in PCR and access to clinical specimens. Applicants must have access to BSL-2 laboratories and be eligible to conduct in vitro diagnostic validation studies per applicable regulations.

応募する前に、必ず公式サイトで詳細を確認してください。 誤りを見つけましたか?お知らせください。

類似の機会

Opportunity Newsletter

最新の優れた奨学金・コンペ・プログラムを、あなたの国・レベル・関心に合わせて毎週メールでお届けします。

✓ 毎週 ✓ パーソナライズ ✓ 100% 無料